Anaptysbio (ANAB) Other Non-Current Liabilities (2016 - 2026)
Anaptysbio's Other Non-Current Liabilities was $263.74 million in Q1 2026, down 20.2% from $330.38 million a year earlier and down 4.6% from the prior quarter.
Anaptysbio (ANAB) Other Non-Current Liabilities (2016 - 2026) Analysis & Trends
At the end of FY2025, Other Non-Current Liabilities at Anaptysbio came in at $276.53 million, down 21.8% from FY2024.
- Other Non-Current Liabilities shows a four-year compound annual growth rate of 2.4% (FY2021 to FY2025).
- In earlier years, Other Non-Current Liabilities was $353.43 million in FY2024 (+13.7%), $310.81 million in FY2023 (+2.1%), $304.41 million in FY2022 (+21.2%) and $251.09 million in FY2021.
- The Q1 2026 figure marks the lowest quarterly Other Non-Current Liabilities since Q2 2022.
- Compared with a year earlier, Other Non-Current Liabilities has declined for four straight quarters, with an average decline of 0.8% over the last eight quarters.
- The best year-over-year quarter for Other Non-Current Liabilities over five years was Q4 2022 (growth of 21.2%); the worst was Q4 2025 (a decline of 21.8%).
- Per Business Quant data, ANAB's Other Non-Current Liabilities in the three quarters before Q1 2026 was $276.53 million (Q4 2025), $331.84 million (Q3 2025) and $331.36 million (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Anaptysbio | 1.46 Bn | 346.34 Mn | - |
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 263.74 Mn |
| Dec 31, 2025 | 276.53 Mn |
| Sep 30, 2025 | 331.84 Mn |
| Jun 30, 2025 | 331.36 Mn |
| Mar 31, 2025 | 330.38 Mn |
| Dec 31, 2024 | 353.43 Mn |
| Sep 30, 2024 | 350.56 Mn |
| Jun 30, 2024 | 361.98 Mn |
| Mar 31, 2024 | 310.18 Mn |
| Dec 31, 2023 | 310.81 Mn |
| Sep 30, 2023 | 311.27 Mn |
| Jun 30, 2023 | 310.07 Mn |
| Mar 31, 2023 | 307.52 Mn |
| Dec 31, 2022 | 304.41 Mn |
| Sep 30, 2022 | 301.59 Mn |
| Jun 30, 2022 | 261.02 Mn |
| Mar 31, 2022 | 255.58 Mn |
| Dec 31, 2021 | 251.09 Mn |
| Sep 30, 2020 | 33,000.00 |
| Jun 30, 2020 | 180,000.00 |
Anaptysbio Other Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=ANAB&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-liabilities", "ticker": "ANAB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=ANAB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();